Rezultati - Alrashed, Fatema

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis

    Impact of biologics and small molecules for inflammatory bowel disease on COVID‐19‐related hospitalization and mortality: A systematic review and meta‐analysis od Alrashed, Fatema, Alasfour, Hajer, Shehab, Mohammad

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study

    COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study od Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis

    Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis od Shehab, Mohammad, Alrashed, Fatema, Shuaibi, Sameera, Alajmi, Dhuha, Barkun, Alan

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

    Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis od Alrashed, Fatema, Battat, Robert, Abdullah, Israa, Charabaty, Aline, Shehab, Mohammad

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study

    Impact of BNT162b2 mRNA Vaccination on the Development of Short and Long-Term Vaccine-Related Adverse Events in Inflammatory Bowel Disease: A Multi-Center Prospective Study od Shehab, Mohammad, Alrashed, Fatema, Abdullah, Israa, Alfadhli, Ahmad, Ali, Hamad, Abu-Farha, Mohamed, Channanath, Arshad Mohamed, Abubaker, Jehad Ahmed, Al-Mulla, Fahd

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study

    Immunogenicity of BNT162b2 Vaccine in Patients with Inflammatory Bowel Disease on Infliximab Combination Therapy: A Multicenter Prospective Study od Shehab, Mohammad, Abu-Farha, Mohamed, Alrashed, Fatema, Alfadhli, Ahmad, Alotaibi, Khazna, Alsahli, Abdullah, Alphonse Thanaraj, Thangavel, Channanath, Arshad, Ali, Hamad, Abubaker, Jehad, Almulla, Fahd

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies

    Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies od Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad, Alotaibi, Khazna, Alsahli, Abdullah, Mohammad, Hussain, Cherian, Preethi, Al-Khairi, Irina, Alphonse Thanaraj, Thangavel, Channanath, Arshad, Ali, Hamad, Abu-Farha, Mohamed, Abubaker, Jehad, Al-Mulla, Fahd

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study

    Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study od Shehab, Mohammad, Alrashed, Fatema, Alfadhli, Ahmad, Alsayegh, Abdulwahab, Aldallal, Usama, Alsayegh, Mariam, Cherian, Preethi, Alkhair, Irina, Thanaraj, Thangavel Alphonse, Channanath, Arshad, Dashti, Ali A., Albanaw, Anwar, Ali, Hamad, Abu-Farha, Mohamed, Abubaker, Jehad, Al-Mulla, Fahd

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: